Pure-play Quantum · Corporate VC

Honeywell (Quantinuum parent)

Honeywell merged its Quantum Solutions business with Cambridge Quantum in 2021 to form Quantinuum (trapped-ion quantum computing). Quantinuum priced its Nasdaq IPO (QNT) at $60 per share on June 3, 2026, raising $1.68B, and began trading June 4; Honeywell remains the anchor shareholder with about 48% of voting power.

Active Charlotte, United StatesFounded 2021

Investment thesis

Honeywell's quantum exposure runs through Quantinuum, formed in November 2021 by merging Honeywell Quantum Solutions with Cambridge Quantum. Honeywell does not run a dedicated quantum CVC fund: it holds the stake directly on its balance sheet and has reinvested in every round, including the $300M raise at a $5B pre-money valuation in January 2024 (anchored by JPMorgan Chase) and the September 2025 round at a $10B pre-money valuation, upsized from $600M to roughly $800M after oversubscription, with Fidelity International, Quanta Computer, NVIDIA NVentures, QED Investors, MESH and Korea Investment Partners joining JPMorganChase, Mitsui, Amgen, Cambridge Quantum Holdings and Serendipity Capital.

Quantinuum completed its Nasdaq IPO in June 2026: 28 million Class A shares priced at $60.00 on June 3rd (above an already raised range), raising $1.68B, with trading under QNT starting June 4th and the stock opening at $68. Honeywell retains approximately 48.1% of combined voting power post-offering, with Honeywell CEO Vimal Kapur chairing Quantinuum's board, making Honeywell the anchor shareholder of a newly public quantum company rather than a classic minority CVC.

Quantinuum builds trapped-ion systems on the QCCD architecture, claiming the industry's highest two-qubit gate fidelity. Helios launched commercially in November 2025 with 98 physical qubits delivering 48 error-corrected logical qubits (a 2:1 encoding rate), with early collaborators including Amgen, BMW Group, JPMorgan Chase and SoftBank. The roadmap targets Sol (2027, first 2D-grid system) and Apollo (2029, universal fault-tolerant machine). In May 2026 Quantinuum signed a letter of intent with the U.S. Department of Commerce's CHIPS R&D Office for federal funding alongside GlobalFoundries and Monarch Quantum.

For founders, Honeywell's value-add is industrial: manufacturing scale-up, control systems and automation, plus channel access through its automation businesses. But Honeywell itself is splitting into three companies (Solstice Advanced Materials spun off in October 2025; Honeywell Aerospace expected in Q3 2026), so any pitch must map to the remaining automation-focused Honeywell and complement, not compete with, Quantinuum's stack.

Anti-thesis

The patterns that trigger a fast no with this fund.

  1. Honeywell's public quantum strategy runs through Quantinuum, in which it holds about 48% of voting power post-IPO; direct minority investments in competing trapped-ion or full-stack quantum companies are very unlikely to clear
  2. There is no dedicated Honeywell quantum CVC fund: the only sizeable outside quantum bets on record were Honeywell Ventures' 2020 stakes in Cambridge Quantum (absorbed into Quantinuum) and Zapata Computing (ceased operations in October 2024), so do not expect a programmatic check
  3. Honeywell is splitting into three companies (Solstice Advanced Materials spun off October 2025, Honeywell Aerospace expected Q3 2026); management attention and capital are tied up in the separation, not in new quantum positions
  4. Post-IPO, incremental quantum exposure for Honeywell means supporting QNT, not writing new private checks; a startup is more likely to land as a Quantinuum partner or supplier than as a Honeywell portfolio company

Notable quantum portfolio

Full portfolio
Quantinuum

Frequent co-investors

  • JPMorganChase
  • Mitsui
  • Amgen
  • NVIDIA NVentures
  • Quanta Computer
  • QED Investors
  • Fidelity International